Edwards to open new manufacturing, R&D facility in Utah
Edwards Lifesciences, a developer of heart valves and hemodynamic monitoring products, is developing a new manufacturing facility in Draper, Utah, which will enable the company to expand its manufacturing and R&D capability.
The Irvine, Calif.-based company accepted incentives from the state of Utah totaling approximately $11.5 million based on the current 228 jobs being retained and more than 1,000 projected new jobs in manufacturing, business and engineering expected to be created in the state during the 15-year incentive period. Edwards also accepted an incentive from Draper for approximately $3 million based on capital investments and employment rates over a seven-year incentive period.
As the first step of its planned expansion, the company will transfer manufacturing of its cannula and embolic protection devices utilized by cardiac surgeons during open-heart surgery from its existing Midvale, Utah, facility to the new facility in Draper in the first half of 2010.
The Irvine, Calif.-based company accepted incentives from the state of Utah totaling approximately $11.5 million based on the current 228 jobs being retained and more than 1,000 projected new jobs in manufacturing, business and engineering expected to be created in the state during the 15-year incentive period. Edwards also accepted an incentive from Draper for approximately $3 million based on capital investments and employment rates over a seven-year incentive period.
As the first step of its planned expansion, the company will transfer manufacturing of its cannula and embolic protection devices utilized by cardiac surgeons during open-heart surgery from its existing Midvale, Utah, facility to the new facility in Draper in the first half of 2010.